TrialThe Lancet. Respiratory medicine2023

Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care.

Pallav L Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.